DP25 Widespread subcutaneous nodular kappa light chain amyloidosis
نویسندگان
چکیده
Abstract A 69-year-old woman was referred to the dermatology department for evaluation of multiple widespread subcutaneous lesions involving neck, torso and limbs. These lesions, initially diagnosed in community as lipomas, had been slowly progressing size number 3 years. She remained systemically well. Her only medical history essential thrombocythaemia. took no regular medication. On examination, there were appreciated on palpation with overlying epidermal change. The patient experiencing pain a sciatic distribution. Magnetic resonance imaging femur showed 12-cm enhancing area nodularity encasing nerve. Computed tomography chest, abdomen pelvis subcutaneous, ill-defined, soft tissue anterior abdominal wall lymphadenopathy or organ abnormality. Deep incisional biopsies from two separate locations completed. There an unremarkable epidermis dermis. In fat, septae appeared thickened alongside elastic fibres prominent multifocal granulomatous reaction high degree elastophagocytosis. aggregates plasma cells that displayed cytological atypia. situ hybridization strong kappa light chain restriction. Plasma protein electrophoresis completed confirmed paraprotein band gamma region IgM kappa. Full blood count revealed platelet (585 × 109 L–1) but otherwise normal renal liver function, bone profile, lactate dehydrogenase, B2 microglobulin, Bence–Jones proteins infection screen. Congo red stain performed original histological samples. This apple green birefringence under polarized light-confirming amyloid. Haematology marrow biopsy, which normal. Referral National Amyloid Centre made. Serum amyloid P scan visceral involvement. diagnosis subtype (AL) has since commenced rituximab, bortezomib (Velcade®), cyclophosphamide dexamethasone (R-VCD) chemotherapy at 4-weekly intervals over 4-month period. Primary localized cutaneous amyloidosis is characterized by extracellular deposition skin without evidence systemic involvement often subtyped into macular, papular nodular. Amyloidoma (tumoral amyloidosis) rare defined solitary deposit are four case reports literature deposits, one these cases AL (light chain) vs. (AA) subtype. nodules restricted neck (Nguyen TU, Oghalai JS, McGregor DK et al. Subcutaneous nodular amyloidosis: report review literature. Hum Pathol 2001; 32:346–8). To our knowledge, this first amyloidosis.
منابع مشابه
Light Chain Amyloidosis
Light chain (AL) amyloidosis is caused by a usually small plasma-cell clone that is able to produce the amyloidogenic light chains. They are able to misfold and aggregate, deposit in tissues in the form of amyloid fibrils and lead to irreversible organ dysfunction and eventually death if treatment is late or ineffective. Cardiac damage is the most important prognostic determinant. The risk of d...
متن کاملAtypical immunoglobulin light chain amyloidosis
BACKGROUND Primary immunoglobulin light chain amyloidosis (AL amyloidosis) is a plasma cell disorder which mainly affects heart, kidneys, liver, and peripheral nervous system. Cases of atypical AL amyloidosis presented as spontaneous vertebral compression fractures have been rarely reported, and data about the management and clinical outcomes of the patients are scarce. METHODS Herein, we pre...
متن کاملNeuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
INTRODUCTION Randomized studies have shown that bortezomib (BTZ) can be given weekly via intravenous (IV) route or twice weekly via subcutaneous (SC) route with lower neuropathy risk and no loss of anti-myeloma efficacy compared to original standard IV twice weekly schedule. Weekly SC should therefore yield the best therapeutic index and is widely used but has not been compared to established a...
متن کاملAtrophic nodular cutaneous amyloidosis*
Primary cutaneous amyloidosis is limited to the skin without involving any other tissue. Nodular amyloidosis is rare, and atrophic nodular cutaneous amyloidosis is even rarer. We describe the fourth case of atrophic nodular cutaneous amyloidosis by searching PubMed databases. A 52-year-old female presented to our hospital with a 2-year history of orange papules and nodules without subjective sy...
متن کاملLight-chain (AL) amyloidosis: diagnosis and treatment.
Light-chain (AL) amyloidosis is the most common form of systemic amyloidosis and is associated with an underlying plasma cell dyscrasia. The disease often is difficult to recognize because of its broad range of manifestations and what often are vague symptoms. The clinical syndromes at presentation include nephrotic-range proteinuria with or without renal dysfunction, hepatomegaly, congestive h...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Dermatology
سال: 2023
ISSN: ['1365-2133', '0007-0963']
DOI: https://doi.org/10.1093/bjd/ljad113.238